Medical Stocks in the News: Celldex Therapeutics (NASDAQ:CLDX), NeuroMetrix (NASDAQ:NURO)

Celldex Therapeutics (NASDAQ:CLDX) is lower Monday afternoon after its net loss  widened and revenue declined compared to the year-ago period. Results were better than Wall Street’s expectations but could not fend off sellers. In early afternoon action, shares of the biopharmaceutical company are down 11% at $26.15 and traded earlier as low as $25.76. The stock…

Read More

Magna International (NYSE:MGA) Stock Reaches All Time High; Pacific Ethanol (NASDAQ:PEIX) Surges

Magna International (NYSE:MGA) shares reached their all-time high Monday after the company reported improved Q4 financial results and said it expects fiscal 2014 revenue about in line with estimates. Near midday, Magna International (NYSE:MGA) shares are up 2.5% at $91.32, and earlier hit a record high of $92.42. The automotive supplier reported Q4 earnings of $2.03…

Read More

Dendreon (NASDAQ:DNDN) Shares Soar

Shares of Dendreon (NASDAQ:DNDN) gained 16% in late morning trade Monday as investors responded enthusiastically to the biotechnology company’s Q4 results and its announcement it will make its Provenge prostate-cancer treatment commercially available in Germany and the U.K. The company reported a narrower-than-expected Q4 adjusted loss on revenue that was above Street estimates and saw…

Read More

Earnings Movers – Exlservice Holdings Inc. (NASDAQ:EXLS), HCA Holdings, Inc. (NYSE:HCA), Corporate Resource Services (NASDAQ:CRRS)

Exlservice Holdings Inc. (NASDAQ:EXLS) rose 7.1% after the company reported Q4 earnings that beat analysts’ estimates. The consulting company said adjusted Q4 earnings increased 25% from a year earlier to $0.55 a share, exceeding estimates on Capital IQ of $0.49. Exlservice Holdings Inc. (NASDAQ:EXLS)  had diluted earnings per share of $0.47 compared to $0.36 a year…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓